Jeffrey Durgin, MD
Surgery · Clovis, NMNPI 1598750424
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.7%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 87.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $7,689 and has fallen 91.9% since, to $626 in 2025.
Across 83 payments — averaging $163.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$12K
- Medical Device Business Services, Inc.$762
- Apollo Endosurgery US Inc$574
- Johnson & Johnson$144
- Potrero Medical, Inc.$63
- AbbVie$32
- plus $126 from 7 others
What the payments were for
- Travel & lodging$6,08145%
- Food & beverage$2,01015%
- Education$5,50040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 56 | $11,890 |
| Medical Device Business Services, Inc. | 4 | $762 |
| Apollo Endosurgery US Inc | 8 | $574 |
| Johnson & Johnson | 4 | $144 |
| Potrero Medical, Inc. | 2 | $63 |
| AbbVie | 2 | $32 |
| Davol Inc. | 1 | $30 |
| Innovation Technologies Inc | 1 | $26 |
| Acell, Inc. | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Organogenesis Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,591 in reported general payments places this provider in the 85th percentile of 162 surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 64 | $4,216 |
| Metronidazole | 11 | $496 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $245 |
| Omeprazole | 27 | $179 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $134 |
| Doxycycline Hyclate | 12 | $128 |
| Cephalexin | 17 | $128 |
| Tizanidine Hcl | 15 | $51 |
| Ciprofloxacin Hcl | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other surgery in Clovis
- Mario LeybaAlbuquerque$1.2M
- Michael BleaAlbuquerque$420K
- David HoangAlbuquerque$264K
- Erica McBrideAlbuquerque$95K
- Fermin FontanLas Cruces$87K
- Gregory BorahAlbuquerque$77K
- Edward AuyangAlbuquerque$70K
- Jacquelyn BrandenburgAlbuquerque$60K
- Jay ZhuAlbuquerque$57K
- Brian HoltAlbuquerque$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.